Pfizer Retro-Commissioning
Field Engineering Services

Project Profile:

Project:		Pfizer, Morris Plains
Owner:		Pfizer, Inc.
Project Type:		Pharmaceutical
Square Footage:		1.2 m sf
Completion Date:		June 2003

Project Details:
Located in Morris Plains, NJ, Pfizer, Inc. consists of 4 separate buildings, totaling over 1.2 million sf.  The site was originally constructed for use as a manufacturing and warehouse space, but has been systematically converted to office space and pilot plant facilities.

As the site's use changed over time, the existing HVAC systems were gradually modified and upgraded.  This type of system conversion/ reutilization often leads to compromises in performance and increased energy consumption.  In order to ensure that their systems were indeed operating at peak efficiency, Pfizer looked to the Retro-commissioning process.

Retro-cx is a systematic process of reviews, inspections and testing which ensures systems have been designed, installed and operate to efficiently meet the needs of the building's occupants.  The scope of the project included rigorous, hands-on inspections and testing of the HVAC equipment and building automation system.  All identified issues were documented and quantified such that their resolution could be prioritized.

Pfizer was one of the few companies that took advantage of a short term NJ Smart Start incentive program that provided 50% of the funding for Retro-cx projects.

Dome-Tech's original scope of work included Building 2 (428,000 sf).  The Building 2 project identified numerous, low cost, easy to implement energy conservation opportunities.  In addition, a number of advantageous capital projects were identified.  The results of the Building 2 project prompted Pfizer to apply the Retro-cx process to the remaining three buildings.  These projects were implemented despite the absence of incentive money, as retro-cx incentives were removed from the NJ Smart Start program.  These projects also identified numerous energy conservation opportunities.  Site wide, $600,000 in energy conservation opportunities were identified.

Pfizer has seen the benefits of resolving issues identified through the retro-cx process reflected in their energy use.  Since issue resolution began in September of 2002, Pfizer has experienced a 21% net decrease in energy consumption per degree day.  This reduction in energy consumption was achieved despite the addition of a data center, which added approximately 750 kW of additional load of the facility.